ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 145 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,722 | -27.5% | 3,901 | +9.7% | 0.00% | -50.0% |
| Q2 2023 | $36,876 | +60.8% | 3,556 | +25.5% | 0.00% | +100.0% |
| Q1 2023 | $22,927 | -66.7% | 2,834 | -35.2% | 0.00% | -66.7% |
| Q4 2022 | $68,891 | +20.6% | 4,374 | +20.5% | 0.00% | 0.0% |
| Q3 2022 | $57,120 | +12.7% | 3,629 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $50,661 | -1.9% | 3,629 | +21.1% | 0.00% | 0.0% |
| Q1 2022 | $51,651 | -72.0% | 2,996 | -76.4% | 0.00% | -33.3% |
| Q4 2021 | $184,600 | -19.2% | 12,696 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $228,528 | +2.5% | 12,696 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $222,942 | +149.8% | 12,696 | +5.1% | 0.00% | +50.0% |
| Q4 2018 | $89,256 | -44.4% | 12,078 | +9.2% | 0.00% | -33.3% |
| Q3 2018 | $160,533 | -99.9% | 11,056 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $220,788,000 | +68.8% | 11,056 | +48.1% | 0.00% | +100.0% |
| Q1 2018 | $130,821,000 | +70998.4% | 7,467 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $184,000 | -50.4% | 7,467 | -48.1% | 0.00% | 0.0% |
| Q3 2017 | $371,000 | -4.9% | 14,374 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $390,000 | +62.5% | 14,374 | +78.3% | 0.00% | +50.0% |
| Q1 2017 | $240,000 | +9.6% | 8,061 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $219,000 | +6.3% | 8,061 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $206,000 | – | 8,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |